Brief: PCI Biotech Reduces Personnel, Extends Wind-Down Of Ops
Sept 25 (Reuters) - PCI Biotech Holding ASA PCIB.OL: BIOTECH UPDATE ON FUTURE OPERATIONS CURRENT OPERATIONS ARE FOCUSED SOLELY ON EVALUATION OF NEW BIOPROCESSING TECHNOLOGY BY UNDISCLOSED PARTY INITIATES DOWNSIZING OF PERSONNEL AND EXTENDS WIND-DOWN OF OPERATIONS TECHNOLOGY EVALUATION IS CONDUCTED UNDER MATERIAL TRANSFER AGREEMENT WITHOUT FINANCIAL TERMS Source text: ID:nGNE4RNy69 Further company coverage: PCIB.OL (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on PCI Biotech Holding ASA
See all newsBrief: Euronext Oslo Børs To Delist PCI Biotech Holding Shares
Brief: Euronext Oslo Børs Gets Application From PCI Biotech Holding For Delisting
Brief: PCI Biotech Holding Board Proposes Dissolution, Delisting
Brief: Oslo Bors: PCI Biotech Holding Is Placed In Recovery Box
Brief: PCI Biotech Says Co Initiates Process To Evaluate Opportunity For Structured Wind-Up Process